Prudent Man Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Prudent Man Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,627	Closed	-$261K	–	201
2020 Q4	$261K	Buy	+3,627	New	+$190K	0.11%	141

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Prudent Man Advisors's BEAT Position: Q1 2021 in Review

Prudent Man Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 3,627 shares — an estimated $261K sold.

Prudent Man Advisors first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $261K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Prudent Man Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Prudent Man Advisors sold 3,627 BioTelemetry, Inc. shares in Q1 2021, an estimated $261K.
Prudent Man Advisors first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
Prudent Man Advisors's BioTelemetry, Inc. position peaked at $261K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Prudent Man Advisors's 13F filing for Q1 2021, filed 14 May 2021.